Skip to content

Diagnostic value of OCTA in diabetic cerebral microvascular disease

Diagnostic value of OCTA in diabetic cerebral microvascular disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038814
Enrollment
Unknown
Registered
2020-10-04
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus complicated with cerebral small vessel disease

Interventions

Gold Standard:According to the "Consensus on Diagnosis and Treatment of Cerebrovascular Diseases in China" in 2015, the diagnostic criteria are recommended 1. The clinical manifestation of cerebral s
Index test:The&#32
of&#32
FAZ&#32
and&#32
blood&#32
flow&#32
in&#32
the&#32
both&#32
eyes&#32
were&#32
by&#32

Sponsors

The Second Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria of normal control group were as follows 1. Subjects with education level of primary school or above; 2. Subjects with corrected visual acuity >= 4.9 (standard logarithmic visual acuity chart); 3. Subjects with diopter less than or equal to ± 3.0d; 4. Subjects with IOP = 4.6 (standard logarithmic visual acuity chart); 5. Subjects with diopter less than or equal to ± 3.0d; 6. Subjects with IOP <= 21mmhg (1mmhg = 0.133kpa) denied history of ocular hypertension; 7. Subjects with no previous history of intraocular surgery, laser and trauma; 8. No obvious abnormality of anterior segment was found in slit lamp examination.

Exclusion criteria

Exclusion criteria: Diabetes or other serious diseases; other causes of small cerebral vessels; other factors affecting cognitive function 1. Acute complications of diabetes mellitus; 2. Severe chronic complications; 3. Identify inflammatory diseases; 4. Autoimmune diseases; 5. History of tumor; 6. History of hereditary cerebrovascular disease; 7. Alzheimer's disease related dementia; 8. History of head trauma or stroke and other neurological diseases; 9. Vitamin B deficiency; 10. History of thyroid dysfunction; 11. History of exposure to poisons; (Note: points 9-11 mainly affect peripheral neuropathy, but have little effect on cerebral small vessel disease) The influencing factors of eye diseases were as follows 12. Diseases with obvious refractive medium turbidity affecting fundus examination and inability to fix vision; 13. Other fundus diseases other than diabetic retinopathy, such as glaucoma (which has been excluded in the inclusion criteria), age-related macular degeneration, high myopia (which has been excluded in the inclusion criteria); 14. Hypertensive retinopathy; 15. Ischemic optic neuropathy; 16. Central serous chorioretinopathy and other retinopathy that may interfere with OCT analysis.

Design outcomes

Primary

MeasureTime frame
Size of avascular zone in fovea retinae;Blood flow density;

Countries

China

Contacts

Public ContactXiahong Lin

The Second Affiliated Hospital of Fujian Medical University

2413368792@qq.com+86 18965732072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026